HCA Healthcare, Inc. reported results for the second quarter of 2026 with revenue of $20.23B and diluted EPS of $7.62, versus $18.61B in revenue and $6.83 EPS in Q2 2025. Net income attributable to HCA Healthcare, Inc. was $1.699B, up modestly year over year.
Financial Highlights
- Revenue was $20.23B, compared with $18.61B in the prior-year quarter; YoY change 8.7%.
- Net income was $1.699B, compared with $1.653B in the prior-year quarter; YoY change 2.8%.
- Diluted EPS was $7.62, compared with $6.83 in the prior-year quarter; YoY change 11.6%.
Business Highlights
- Revenue growth was driven by higher revenue per equivalent admission and volume gains, with consolidated revenues rising 8.7% (same-facility growth of 9.3%).
- Channel and payer mix shifted as uninsured admissions surged ~23% following EPTC expiration, lowering managed care/Exchange revenues and increasing uncompensated care.
- Material incremental Medicaid directed and supplemental payments, notably in Florida, added significant revenue but also matching expenses.
- Operational volumes: admissions and ED visits increased modestly while inpatient and outpatient surgical volumes declined, reducing outpatient revenue share.
- Cost pressures: other operating expenses (including professional fees and SDP costs) and inflation weighed on operating margins despite stable labor ratios.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.